Research article · 31 Jan 2022
Conference abstractPublished 27 Jul 2015
Rotavirus vaccines: development, implementation and impact
University of Melbourne, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rotavirus is the most common cause of severe dehydrating gastroenteritis worldwide, causing about 450,000 deaths per year in children < 5 years of age and hospitalizing millions more. Rotavirus vaccines have been associated with a reduction in rotavirus hospitalisations in low- and high-income countries and a reduction in death in young children in Mexico and Brazil. In 2009, the WHO recommended that all children be vaccinated against rotavirus. Today 78 countries administer rotavirus vaccines in the National Immunisation Program, including some of the world’s poorest countries assisted by GAVI. Rotavirus vaccines have been demonstrated to be highly cost-effective and data is now emerging of the indirect benefits of rotavirus vaccination. Despite these significant achievements there remain some challenges to the success of rotavirus vaccines, including vaccine efficacy in regions with high rates of severe disease, burden on the cold chain, safety concerns and cost. These challenges are the focus of ongoing research and development efforts. The RV3-BB rotavirus vaccine is a human neonatal rotavirus vaccine under development at Murdoch Childrens Research Institute, Australia. RV3-BB is an oral vaccine targeting birth dose administration and has the potential to improve the effectiveness and safety of rotavirus vaccines in low-income countries.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 6 Nov 2023
Rotavirus Vaccines: Transforming Pediatric Healthcare Worldwide
Research article · 22 Jul 2020
Prevalence of Rotavirus Genotypes after Introduction of Monovalent Rotavirus Vaccine in Uzbekistan during 2014-2016
Short communication · 2 May 2019
Prevalence of rotavirus genotypes after introduction of monovalent rotavirus vaccine in Uzbekistan during 2014-2016
Conference abstract · 24 Nov 2016
Human Rotavirus vaccine: A decade of experience vaccinating infants worldwide
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Julie E. Bines”
